InsiderTrades.com logo

MPH Insider Trading

Insider Ownership Percentage: 26.68%
Insider Buying (Last 12 Months): C$22,000.00
Insider Selling (Last 12 Months): C$0.00

Medicure Insider Trading History Chart

This chart shows the insider buying and selling history at Medicure by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Medicure Share Price & Price History

Current Price: C$1.25
Price Change: ▲ Price Increase of +0.05 (4.17%)
As of 06/22/2026 02:02 PM ET

This chart shows the closing price history over time for MPH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Medicure Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/19/2026Albert David FriesenDirectorBuy2,000C$1.22C$2,440.00552,767
6/19/2026Albert David FriesenDirectorBuy16,300C$1.20C$19,560.00550,767
See Full Table

SEC Filings (Institutional Ownership Changes) for Medicure (CVE:MPH)

4.85% of Medicure stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Medicure logo
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.
Read More on Medicure

Today's Range

Now: C$1.25
Low: C$1.20
High: C$1.25

50 Day Range

MA: C$1.15
Low: C$0.90
High: C$1.35

52 Week Range

Now: C$1.25
Low: C$0.85
High: C$1.43

Volume

3,700 shs

Average Volume

3,087 shs

Market Capitalization

C$13.05 million

P/E Ratio

N/A

Dividend Yield

2.24%

Beta

0.536473

Who are the company insiders with the largest holdings of Medicure?

Medicure's top insider shareholders include:
  1. Albert David Friesen (Director)
  2. Neil Wayne Owens (Senior Officer)
  3. Elliott International Capital (Insider)
  4. Graeme William Merchant (Insider)
Learn More about top insider investors at Medicure.